Clinical Trials Logo

Enuresis clinical trials

View clinical trials related to Enuresis.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06468891 Recruiting - Clinical trials for Stress Urinary Incontinence

Analyzing Gait Parameters Among Women With and Without Stress Urinary Incontinence

GPWSUI
Start date: June 16, 2024
Phase:
Study type: Observational

This study will contribute to the existing body of knowledge on stress urinary incontinence and its impact on gait. The findings may have implications for the development of targeted interventions and rehabilitation strategies to improve mobility and quality of life in women with stress urinary incontinence

NCT ID: NCT06465576 Recruiting - Clinical trials for Urinary Incontinence in Children

Strategy for Withdrawal of Pharmacological Treatment for Urinary Incontinence in Children (StayDry)

Start date: May 27, 2024
Phase: Phase 4
Study type: Interventional

The primary objective is to investigate if abrupt withdrawal versus gradual withdrawal of pharmacotherapy (solifenacin and/or mirabegron) influences the risk of recurrence of incontinence. Children aged 5-14 years diagnosed with urinary incontinence, treated with pharmacotherapy of solifenacin and/or mirabegron and ready for withdrawal will be randomized 1:1 to either abrupt or gradual withdrawal, according to the medical treatment that the child is receiving.

NCT ID: NCT06443268 Recruiting - Quality of Life Clinical Trials

Cerebrovascular Disease: Quality of Life (CODE: QoL)

CODE:QoL
Start date: May 27, 2023
Phase:
Study type: Observational

The goal of this observational study is to learn about quality of life, stress and caregiver burden in patients with stroke and their caregivers. The main question is: • to discover the factors associated with quality of life and stress in patient-caregiver dyads. Participants will be asked to fill out questionnaires and agree to provide a hair sample (in order to measure stress hormones in hair) and consent to use of their routine clinical and laboratory data. Researchers will compare a group of participants without stroke to establish a comparable baseline.

NCT ID: NCT06389838 Recruiting - Clinical trials for Urinary Incontinence

RCT on Multimodal Self-treatment for Women With Incontinence Using a Digital Health Application

DINKS
Start date: April 30, 2024
Phase: N/A
Study type: Interventional

This study, titled "Prospective Randomized Study on Multimodal Self-Treatment for Women with Incontinence Symptoms Using a Digital Health Application," abbreviated as DINKS, aims to investigate the efficacy of a digital health application in treating incontinence in women. The study involves a single-center, single blinded, randomized, controlled trial with two arms: one receiving digital therapy intervention and the other serving as a control group with standard of care. The primary objective is to reduce the frequency of incontinence episodes over a 12-week intervention period, with secondary goals including improvements in disease symptoms, quality of life, and patient activation. The study plans to recruit 198 female participants and assess various endpoints related to incontinence severity, quality of life, and treatment outcomes.

NCT ID: NCT06384716 Recruiting - Multiple Sclerosis Clinical Trials

Evaluation of the Influence of a Core Muscle Control-Based Rehabilitation Program Patients With Multiple Sclerosis

Start date: February 19, 2024
Phase: N/A
Study type: Interventional

Given the structural relationship of the CORE as a whole, in this study we propose an intervention based on the global motor control of all the structures that make up the CORE to assess its effectiveness on urinary incontinence, sexual dysfunction and balance, as well as its relationship with respiratory function. According to our hypothesis, a global intervention could also be taken into account during conventional treatment in the future, helping to prevent genitourinary dysfunctions derived from alterations in motor control.

NCT ID: NCT06352879 Recruiting - Clinical trials for Urinary Incontinence

Prevalence, Types and Risk Factors of Urinary Incontinence Among Women in Baghdad, Iraq.

Start date: March 1, 2024
Phase:
Study type: Observational

The goal of this observational study is to observe and describe the prevalence, types, and risk factors of urinary incontinence (UI) in adult women attending primary healthcare centers in Baghdad, Iraq. The main questions it aims to answer are: - What is the prevalence of incontinence among the targeted group? - What are the types of incontinence and what is the frequency of each type among the targeted group? - What is the effect of several risk factors on the occurrence and severity of urinary incontinence (including age, job, sexual activity, chronic constipation, chronic cough, parity, largest birth weight, and body mass index)? Participants will be asked to fill out a questionnaire consisting of the Arabic International Consultation On Incontinence Questionnaire-Urinary Incontinence Short Form (Arabic ICIQ-UI SF) in addition to questions about the aforementioned risk factors.

NCT ID: NCT06336304 Recruiting - Clinical trials for Urinary Incontinence

NXT Post-Market Clinical Follow-up

Start date: June 18, 2024
Phase:
Study type: Observational

NXT Urodynamics System Post-Market Clinical Follow-up Clinical Investigation to Confirm Ongoing Safety and Performance in Urodynamic Patient Sub-Populations

NCT ID: NCT06287658 Recruiting - Quality of Life Clinical Trials

The Effect of Kegel Exercise and Ba Duan Jin Applications on Premenopausal Women With Urinary Incontinence

Start date: April 1, 2024
Phase: N/A
Study type: Interventional

This study aimed to determine the effects of Kegel exercise and Ba Duan Jin applications applied to premenopausal women with urinary incontinence on quality of life and psychological well-being. Study Group of the Research: Premenopausal women between the ages of 45-55 who come to the family health center with any complaint and have urinary incontinence. The research will be conducted as a randomized pre-test, post-test and control group intervention study design. The research will be conducted with women aged 45-55 with urinary incontinence who came for examination for any reason to a Family Health Center in Sinop between March 2024 and July 2024. According to the power analysis, the number of participants was calculated to be at least 54 when the type 1 error was taken as 0.05, the power was 0.95 and the effect size was medium (0.25) for the two-group design with two repeated measurements. To prevent possible data loss, the sample size was increased by 10% and the total number of participants was determined as 60. A total of 60 women, 30 experimental and 30 control, coming to the Family Health Center will be randomly included in the study. No information, Kegel exercise program and Ba Duan Jin applications will be given to the women in the experimental group, and no intervention will be given to the control group during the research process. Participants will be assigned to 2 groups: experimental and control. Those who come to FHC on odd days of the month will be included in the experimental group, and those who come on even days of the month will be included in the control group. Each group will be determined as 30 people. After the research is completed, the interventions applied to the experimental group will be applied to the women in the control group. Personal Information Form, Psychological Well-Being Scale and Incontinence Quality of Life Scale will be applied to women in the experimental and control groups as pre-test measurements. As a final test, the same measurements will be made to both the control group and the experimental group 16 weeks after the first measurement.

NCT ID: NCT06285006 Recruiting - Nocturnal Enuresis Clinical Trials

Desmopressin Monotherapy for Monosymptomatic Nocturnal Enuresis

Start date: February 23, 2024
Phase: N/A
Study type: Interventional

Nocturnal Enuresis (NE) is defined as the involuntary passage of urine during sleep past the age of usual control, which is considered a developmental age of 5 to 7 years. NE is a common problem that causes distress to both children and their families. It has an adverse impact on behavior and social life, affects self-esteem, and can result in poor emotional well-being. In Egypt, the prevalence of NE in primary school children is about 15.4%. The family history was seen to have had a markedly significant impact on the occurrence of NE in the studied children. The mainstay of treatment is urotherapy with information and psychoeducation about normal lower urinary tract function, the underlying cause of MNE, disturbed bladder dysfunction in the child with NMNE, and instructions about therapeutic strategies. Alarm therapy and desmopressin are effective in randomized trials. Children with NMNE first need treatment of the underlying daytime functional bladder problem before treatment of nocturnal enuresis.

NCT ID: NCT06275945 Recruiting - Clinical trials for Stress Urinary Incontinence

Feasibility Study of A VoRo UrologIc ScaffolD (ARID)

ARID
Start date: April 3, 2023
Phase: Phase 2
Study type: Interventional

The objective of this study is to evaluate the safety and performance of the Voro Urologic Scaffold as a prophylactic treatment for post-prostatectomy stress urinary incontinence. The study is a prospective, multicenter, single arm study. Up to 40 subjects will be treated at up to 3 investigational sites in Panama. Subjects will be followed up post-treatment at catheter removal, 6 weeks post prostatectomy, 3 months, 6 months, 12 months and 2 years.